{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T07:59:38Z","timestamp":1774166378712,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,10,6]],"date-time":"2015-10-06T00:00:00Z","timestamp":1444089600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1245\/s10434-015-4892-6","type":"journal-article","created":{"date-parts":[[2015,10,6]],"date-time":"2015-10-06T15:21:55Z","timestamp":1444144915000},"page":"833-841","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Predictors of Severe Morbidity After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Patients With Colorectal Peritoneal Carcinomatosis"],"prefix":"10.1245","volume":"23","author":[{"given":"Geert A.","family":"Simkens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thijs R.","family":"van Oudheusden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misha D.","family":"Luyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon W.","family":"Nienhuijs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grard A.","family":"Nieuwenhuijzen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harm J.","family":"Rutten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignace H.","family":"de Hingh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,10,6]]},"reference":[{"key":"4892_CR1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1200\/JCO.2009.23.9285","volume":"28","author":"D Elias","year":"2010","unstructured":"Elias D, Gilly F, Boutitie F, et al. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol. 2010;28:63\u20138.","journal-title":"J Clin Oncol."},{"key":"4892_CR2","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/SLA.0b013e3181a45d86","volume":"249","author":"TC Chua","year":"2009","unstructured":"Chua TC, Yan TD, Saxena A, Morris DL. Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure?: a systematic review of morbidity and mortality. Ann Surg. 2009;249:900\u20137.","journal-title":"Ann Surg."},{"key":"4892_CR3","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1097\/DCR.0000000000000149","volume":"57","author":"D Baratti","year":"2014","unstructured":"Baratti D, Kusamura S, Iusco D, et al. Postoperative complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy affect long-term outcome of patients with peritoneal metastases from colorectal cancer: a two-center study of 101 patients. Dis Colon Rectum. 2014;57:858\u201368.","journal-title":"Dis Colon Rectum."},{"key":"4892_CR4","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1245\/s10434-014-4297-y","volume":"22","author":"GA Simkens","year":"2015","unstructured":"Simkens GA, van Oudheusden TR, Luyer MD, et al. Serious postoperative complications affect early recurrence after cytoreductive surgery and HIPEC for colorectal peritoneal carcinomatosis. Ann Surg Oncol. 2015;22:2656\u201362.","journal-title":"Ann Surg Oncol."},{"key":"4892_CR5","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/j.ejso.2014.08.477","volume":"40","author":"C Seretis","year":"2014","unstructured":"Seretis C, Youssef H. Quality of life after cytoreductive surgery and intraoperative hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies: a systematic review. Eur J Surg Oncol. 2014;40:1605\u201313.","journal-title":"Eur J Surg Oncol."},{"key":"4892_CR6","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1007\/s11605-014-2506-4","volume":"18","author":"J Hammond","year":"2014","unstructured":"Hammond J, Lim S, Wan Y, Gao X, Patkar A. The burden of gastrointestinal anastomotic leaks: an evaluation of clinical and economic outcomes. J Gastrointest Surg. 2014;18:1176\u201385.","journal-title":"J Gastrointest Surg."},{"key":"4892_CR7","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/SLA.0b013e31825704e3","volume":"256","author":"D Baratti","year":"2012","unstructured":"Baratti D, Kusamura S, Mingrone E, Balestra MR, Laterza B, Deraco M. Identification of a subgroup of patients at highest risk for complications after surgical cytoreduction and hyperthermic intraperitoneal chemotherapy. Ann Surg. 2012;256:334\u201341.","journal-title":"Ann Surg."},{"key":"4892_CR8","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1245\/s10434-013-3049-8","volume":"20","author":"CU Ihemelandu","year":"2013","unstructured":"Ihemelandu CU, McQuellon R, Shen P, Stewart JH, Votanopoulos K, Levine EA. Predicting postoperative morbidity following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CS\u00a0+\u00a0HIPEC) with preoperative FACT-C (Functional Assessment of Cancer Therapy) and patient-rated performance status. Ann Surg Oncol. 2013;20:3519\u201326.","journal-title":"Ann Surg Oncol."},{"key":"4892_CR9","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/jso.23865","volume":"111","author":"RW Randle","year":"2015","unstructured":"Randle RW, Ahmed S, Levine EA, et al. Significance of diabetes on morbidity and mortality following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. J Surg Oncol. 2015;111:740\u201345.","journal-title":"J Surg Oncol."},{"key":"4892_CR10","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","volume":"30","author":"TC Chua","year":"2012","unstructured":"Chua TC, Moran BJ, Sugarbaker PH, et al. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol. 2012;30:2449\u201356.","journal-title":"J Clin Oncol."},{"key":"4892_CR11","doi-asserted-by":"crossref","first-page":"6237","DOI":"10.1200\/JCO.2009.23.9640","volume":"27","author":"TD Yan","year":"2009","unstructured":"Yan TD, Deraco M, Baratti D, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol. 2009;27:6237\u201342.","journal-title":"J Clin Oncol."},{"key":"4892_CR12","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205\u201313.","journal-title":"Ann Surg."},{"key":"4892_CR13","author":"GA Simkens","year":"2015","unstructured":"Simkens GA, van Oudheusden TR, Braam HJ, et al. Treatment-related mortality after cytoreductive surgery and HIPEC in patients with colorectal peritoneal carcinomatosis is underestimated by conventional parameters. Ann Surg Oncol. 2015. doi: 10.1245\/s10434-015-4699-5 .","journal-title":"Ann Surg Oncol."},{"key":"4892_CR14","first-page":"2621","volume":"21","author":"TR Oudheusden van","year":"2014","unstructured":"van Oudheusden TR, Braam HJ, Nienhuijs SW, et al. Cytoreduction and hyperthermic intraperitoneal chemotherapy: a feasible and effective option for colorectal cancer patients after emergency surgery in the presence of peritoneal carcinomatosis. Ann Surg Oncol. 2014;21:2621\u20136.","journal-title":"Ann Surg Oncol."},{"key":"4892_CR15","unstructured":"Harrell FE Jr. Rms: Regression Modeling Strategies. R package version 4.3\u20131. http:\/\/www.r-project.org\/"},{"key":"4892_CR16","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0895-4356(01)00341-9","volume":"54","author":"EW Steyerberg","year":"2001","unstructured":"Steyerberg EW, Harrell FE Jr., Borsboom GJ, Eijkemans MJ, Vergouwe Y, Habbema JD. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol. 2001;54:774\u201381.","journal-title":"J Clin Epidemiol."},{"key":"4892_CR17","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/EDE.0b013e3181c30fb2","volume":"21","author":"EW Steyerberg","year":"2010","unstructured":"Steyerberg EW, Vickers AJ, Cook NR, et al. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology. 2010;21:128\u201338.","journal-title":"Epidemiology."},{"key":"4892_CR18","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/SLA.0000000000000854","volume":"261","author":"A Artinyan","year":"2015","unstructured":"Artinyan A, Orcutt ST, Anaya DA, Richardson P, Chen GJ, Berger DH. Infectious postoperative complications decrease long-term survival in patients undergoing curative surgery for colorectal cancer: a study of 12,075 patients. Ann Surg. 2015;261:497\u2013505.","journal-title":"Ann Surg."},{"key":"4892_CR19","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1007\/s00268-015-3019-3","volume":"39","author":"Z Yin","year":"2015","unstructured":"Yin Z, Huang X, Ma T, et al. Postoperative complications affect long-term survival outcomes following hepatic resection for colorectal liver metastasis. World J Surg. 2015;39:1818\u201327.","journal-title":"World J Surg."},{"key":"4892_CR20","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1097\/SLA.0b013e31820b4dba","volume":"253","author":"TC Chua","year":"2011","unstructured":"Chua TC, Liauw W, Zhao J, Morris DL. Upfront compared to delayed cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei is associated with considerably lower perioperative morbidity and recurrence rate. Ann Surg. 2011;253:769\u201373.","journal-title":"Ann Surg."},{"key":"4892_CR21","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/SLA.0b013e3182708cc5","volume":"258","author":"A Sharma","year":"2013","unstructured":"Sharma A, Deeb AP, Iannuzzi JC, Rickles AS, Monson JR, Fleming FJ. Tobacco smoking and postoperative outcomes after colorectal surgery. Ann Surg. 2013;258:296\u2013300.","journal-title":"Ann Surg."},{"key":"4892_CR22","first-page":"CD002294","volume":"3","author":"T Thomsen","year":"2014","unstructured":"Thomsen T, Villebro N, Moller AM. Interventions for preoperative smoking cessation. Cochrane Database Syst Rev. 2014;3:CD002294","journal-title":"Cochrane Database Syst Rev."},{"key":"4892_CR23","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.amjsurg.2008.06.037","volume":"196","author":"NP Reuter","year":"2008","unstructured":"Reuter NP, Macgregor JM, Woodall CE, et al. Preoperative performance status predicts outcome following heated intraperitoneal chemotherapy. Am J Surg. 2008;196:909\u201313 (discussion 913\u2013904).","journal-title":"Am J Surg."},{"key":"4892_CR24","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/bjc.2014.376","volume":"111","author":"I Cristobal","year":"2014","unstructured":"Cristobal I, Manso R, Rincon R, et al. Phosphorylated protein phosphatase 2A determines poor outcome in patients with metastatic colorectal cancer. Br J Cancer. 2014;111:756\u201362.","journal-title":"Br J Cancer."},{"key":"4892_CR25","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.ejca.2014.01.005","volume":"50","author":"CF Jehn","year":"2014","unstructured":"Jehn CF, Boning L, Kroning H, Pezzutto A, Luftner D. Influence of comorbidity, age, and performance status on treatment efficacy and safety of cetuximab plus irinotecan in irinotecan-refractory elderly patients with metastatic colorectal cancer. Eur J Cancer. 2014;50:1269\u201375.","journal-title":"Eur J Cancer."},{"key":"4892_CR26","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1245\/s10434-015-4429-z","volume":"22","author":"JL Vugt van","year":"2015","unstructured":"van Vugt JL, Braam HJ, van Oudheusden TR, et al. Skeletal muscle depletion is associated with severe postoperative complications in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol. 2015;22:3625\u201331.","journal-title":"Ann Surg Oncol."},{"key":"4892_CR27","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1245\/s10434-008-0105-x","volume":"15","author":"J Franko","year":"2008","unstructured":"Franko J, Gusani NJ, Holtzman MP, et al. Multivisceral resection does not affect morbidity and survival after cytoreductive surgery and chemoperfusion for carcinomatosis from colorectal cancer. Ann Surg Oncol. 2008;15:3065\u201372.","journal-title":"Ann Surg Oncol."},{"key":"4892_CR28","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.1245\/s10434-013-3145-9","volume":"20","author":"AM Kuijpers","year":"2013","unstructured":"Kuijpers AM, Mirck B, Aalbers AG, et al. Cytoreduction and HIPEC in the Netherlands: nationwide long-term outcome following the Dutch protocol. Ann Surg Oncol. 2013;20:4224\u201330.","journal-title":"Ann Surg Oncol."},{"key":"4892_CR29","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/jso.23546","volume":"109","author":"D Hompes","year":"2014","unstructured":"Hompes D, D\u2019Hoore A, Wolthuis A, et al. The use of oxaliplatin or mitomycin C in HIPEC treatment for peritoneal carcinomatosis from colorectal cancer: a comparative study. J Surg Oncol. 2014;109:527\u201332.","journal-title":"J Surg Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-015-4892-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-015-4892-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-015-4892-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T11:22:10Z","timestamp":1559647330000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-015-4892-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,6]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["4892"],"URL":"https:\/\/doi.org\/10.1245\/s10434-015-4892-6","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,6]]}}}